HIGHLIGHTS
- who: Algeria et al. from the Department of Cardiology , Mustafa Hospital, Place du, er Mai, Sidi M'Hamed, Algiers, Evidera, Metro Building, th Floor, Butterwick, London, DL UK have published the Article: Cost-effectiveness of for Prevention in Patients with Atrial Fibrillation in, in the Journal: (JOURNAL)
- what: The aim of this study was to estimate the economic implications of using compared to anti-coagulations to reduce the risk of in patients with AF from the perspective of the Algerian payer. This study assessed the cost-effectiveness of apixaban compared to other available treatments, including . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.